Pharmacy

Your Article Summary

See Latest Articles

Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis
Journal of Clinical Pharmacy and Therapeutics, 06/05/09

Thomas A et al. - This retrospective study describes practical experience in the management of this rare and severe disease in a referral centre for cystic fibrosis lung transplantation. Voriconazole and caspofungin combination was acceptably safe and was associated with good clinical outcomes in almost all patients. The authors showed that in 15 lung-transplant recipients a median of 12·3 days was required for voriconazole to reach high enough blood levels. Caspofungin in combination with voriconazole provides cover against Aspergillus infection during the period when voriconazole may be at subtherapeutic levels with good tolerability.

Today in Drug Interactions...keeping you current

Receive free subspecialty "5-minute updates" via email

Semi-Mechanistic Population Pharmacokinetic Drug-Drug Interaction Modelling of a Long Half-Life Substrate and Itraconazole
Clinical Pharmacokinetics, 12/18/09

Acetazolamide and midazolam act synergistically to inhibit neuropathic pain
Pain, 12/16/09

Cyclosporine Versus Tacrolimus in Immunosuppressive Maintenance Regimens in Renal Transplants in Brazil: Survival Analysis from 2000 to 2004
Annals of Pharmacotherapy, 12/16/09

 See all of Drug Interactions

Today in Other Drugs...keeping you current

Receive free subspecialty "5-minute updates" via email

Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases
Current Medical Research and Opinion, 12/18/09

Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence
Clinical Interventions in Aging, 12/18/09

Efficacy and safety of a single intrathecal methylprednisolone bolus in chronic complex regional pain syndrome
European Journal of Pain, 12/18/09

 See all of Other Drugs